{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:34:00Z","timestamp":1773282840563,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":219,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.4103\/ijmm.ijmm_20_307","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T04:09:00Z","timestamp":1604462940000},"page":"307-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Assessment of Antibacterial Activity of Levonadifloxacin against Contemporary Gram-positive Clinical Isolates Collected from Various Indian Hospitals using Disk-Diffusion Assay"],"prefix":"10.1016","volume":"38","author":[{"given":"Shrikala","family":"Baliga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhruv K.","family":"Mamtora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varsha","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyadarshini","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.N.","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchitra","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4103\/ijmm.IJMM_20_307_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0057-2018","article-title":"Antibiotic resistance and the MRSA problem","volume":"7","author":"Vestergaard","year":"2019","journal-title":"Microbiol Spectr"},{"key":"10.4103\/ijmm.IJMM_20_307_bib2","series-title":"Antimicrobial resistance: Global report on surveillance","year":"2014"},{"key":"10.4103\/ijmm.IJMM_20_307_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/ijmm.IJMM_16_427","article-title":"Prevalence and genetic mechanisms of antimicrobial resistance in Staphylococcus species: A multicentre report of the Indian Council of Medical Research antimicrobial resistance surveillance network","volume":"35","author":"Rajkumar","year":"2017","journal-title":"Indian J Med Microbiol"},{"key":"10.4103\/ijmm.IJMM_20_307_bib4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4103\/0255-0857.148837","article-title":"Vancomycin MIC creep in methicillin-resistant Staphylococcus aureus (MRSA) isolates from 2006 to 2010 in a hospital in China","volume":"33","author":"Chang","year":"2015","journal-title":"Indian J Med Microbiol"},{"key":"10.4103\/ijmm.IJMM_20_307_bib5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1186\/2047-783X-15-12-533","article-title":"Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin","volume":"15","author":"Estes","year":"2010","journal-title":"Eur J Med Res"},{"key":"10.4103\/ijmm.IJMM_20_307_bib6","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1128\/AAC.01536-10","article-title":"Vancomycin bactericidal activity as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia","volume":"55","author":"Miyazaki","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/ijmm.IJMM_20_307_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5152\/TurkPediatriArs.2015.1133","article-title":"Pancytopenia due to linezolid treatment","volume":"50","author":"Parlak","year":"2015","journal-title":"Turk Pediatri Ars"},{"key":"10.4103\/ijmm.IJMM_20_307_bib8","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/AAC.00641-06","article-title":"The anti-methicillin-resistant Staphylococcus aureus quinolone WCK 771 has potent activity against sequentially selected mutants, has a narrow mutant selection window against quinolone-resistant Staphylococcus aureus, and preferentially targets DNA gyrase","volume":"50","author":"Bhagwat","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/ijmm.IJMM_20_307_bib9","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.2147\/DDDT.S229882","article-title":"Levonadifloxacin, a novel broad-spectrum anti-MRSA benzoquinolizine quinolone agent: Review of current evidence","volume":"13","author":"Bhagwat","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"10.4103\/ijmm.IJMM_20_307_bib10","first-page":"2156","article-title":"Levonadifloxacin, a recently approved benzoquinolizine fluoroquinolone, exhibits potent in vitro activity against contemporary Staphylococcus aureus isolates and Bengal Bay clone isolates collected from a large Indian tertiary care hospital","volume":"75","author":"Bakthavatchalam","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.4103\/ijmm.IJMM_20_307_bib11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4103\/ijmm.IJMM_20_34","article-title":"A comparative assessment of clinical, pharmacological and antimicrobial profile of novel anti-methicillin-resistant Staphylococcus aureus agent levonadifloxacin: Therapeutic role in nosocomial and community infections","volume":"37","author":"Bakthavatchalam","year":"2019","journal-title":"Indian J Med Microbiol"},{"key":"10.4103\/ijmm.IJMM_20_307_bib12","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","first-page":"100","year":"2016"},{"key":"10.4103\/ijmm.IJMM_20_307_bib13","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2019"},{"key":"10.4103\/ijmm.IJMM_20_307_bib14","doi-asserted-by":"crossref","first-page":"e00909","DOI":"10.1128\/AAC.00909-19","article-title":"In vivo pharmacokinetic\/pharmacodynamic targets of levonadifloxacin against Staphylococcus aureus in a Neutropenic Murine Lung Infection Model","volume":"63","author":"Bhagwat","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/ijmm.IJMM_20_307_bib15","unstructured":"Bhagwat S, Ivaturi V, Gobburu J, Takalkar S, Periasamy H, Chavan R, et al. Pharmacokinetic\/Pharmacodynamic (PK\/PD) Target Attainment (TA) Analyses to Support WCK 771 (INN: Levonadifloxacin) Clinical Dose Selection. P-1941, Poster Presented at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID. Amsterdam, Netherlands; 13-16 April, 2019."},{"key":"10.4103\/ijmm.IJMM_20_307_bib16","unstructured":"Hackel M, Bhagwat S, Palwe S, Patel M, Sahm D. Determination of disk diffusion zone and broth dilution MIC Correaltions and Broth Dilution Versus Agar dilution MICs for WCK 771. F-1195, Poster presented at the Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC. San Diego, California; 17-21 September, 2015."},{"key":"10.4103\/ijmm.IJMM_20_307_bib17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/jac\/dkz493","article-title":"In vitro activity of a novel antibacterial agent, levonadifloxacin, against clinical isolates collected in a prospective, multicentre surveillance study in India during 2016-18","volume":"75","author":"Appalaraju","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"10.4103\/ijmm.IJMM_20_307_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2165\/00003495-199958002-00002","article-title":"Mode of action of fluoroquinolones","volume":"58","author":"Hooper","year":"1999","journal-title":"Drugs"},{"key":"10.4103\/ijmm.IJMM_20_307_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00253-011-3557-z","article-title":"Exploiting bacterial DNA gyrase as a drug target: Current state and perspectives","volume":"92","author":"Collin","year":"2011","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.4103\/ijmm.IJMM_20_307_bib20","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1021\/jm050035f","article-title":"A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus","volume":"48","author":"de Souza","year":"2005","journal-title":"J Med Chem"},{"key":"10.4103\/ijmm.IJMM_20_307_bib21","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1128\/AAC.47.4.1410-1415.2003","article-title":"Activity of and resistance to moxifloxacin in Staphylococcus aureus","volume":"47","author":"Ince","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/ijmm.IJMM_20_307_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/eye.2009.29","article-title":"Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India","volume":"24","author":"Reddy","year":"2010","journal-title":"Eye (Lond)"},{"key":"10.4103\/ijmm.IJMM_20_307_bib23","doi-asserted-by":"crossref","first-page":"e02297-17","DOI":"10.1128\/AAC.02297-17","article-title":"Intrapulmonary pharmacokinetics of levonadifloxacin following oral administration of alalevonadifloxacin to healthy adult subjects","volume":"62","author":"Rodvold","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085720315371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085720315371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:19:13Z","timestamp":1759346353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085720315371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":23,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0255085720315371"],"URL":"https:\/\/doi.org\/10.4103\/ijmm.ijmm_20_307","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of Antibacterial Activity of Levonadifloxacin against Contemporary Gram-positive Clinical Isolates Collected from Various Indian Hospitals using Disk-Diffusion Assay","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4103\/ijmm.IJMM_20_307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Indian Journal of Medical Microbiology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}